Does nasal continuous positive airway (nCPAP) treatment improve health related quality of life (HRQoL) in the bed partners of patients with obstructive sleep apnoea (OSA)?

A. R. Proctor, C. G. Billings, J. C. Waterhouse (Sheffield, United Kingdom)

Source: Annual Congress 2003 - Clinical aspects and consequences of sleep related breathing disorders
Session: Clinical aspects and consequences of sleep related breathing disorders
Session type: Thematic Poster Session
Number: 655
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. R. Proctor, C. G. Billings, J. C. Waterhouse (Sheffield, United Kingdom). Does nasal continuous positive airway (nCPAP) treatment improve health related quality of life (HRQoL) in the bed partners of patients with obstructive sleep apnoea (OSA)?. Eur Respir J 2003; 22: Suppl. 45, 655

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of nCPAP on quality of life (QoL) in professionally active patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 113s
Year: 2005

CPAP compliance and quality of life (QOL) according to educational level in obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 724s
Year: 2005

Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS)
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Quality of life (QOL) and CPAP compliance in workers and employees with obstructive sleep apnea (OSA) syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005

Effective patient compliance on nasal continuous positive airway pressure therapy supports an improvement in the quality of life in patients with obstructive sleep apnoea
Source: Eur Respir J 2003; 22: Suppl. 45, 96s
Year: 2003

Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006

Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Source: Sleep and Breathing Conference 2021
Year: 2021

Are health related quality of life (HRQoL) changes maintained after several years treatment with nasal vontinuous positive airway pressure (nCPAP)?
Source: Eur Respir J 2003; 22: Suppl. 45, 94s
Year: 2003

Quality of life among sleep apnea patients before and after treatment with continuous positive airway pressure (CPAP) compared to controls from the general population
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013

Evaluation quality of life, anxiety, and depression in patients with obstructive sleep syndrome before and after three and twelve months of continuous positive airway pressure therapy
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021


Effect of nCPAP on work performance (WP) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 725s
Year: 2005

Impact of CPAP on asthmatic patients with obstructive sleep apnoea
Source: Eur Respir J 2007; 29: 307-311
Year: 2007



Factors determining continuous positive airway pressure (CPAP) compliance in obstructive sleep apnea (OSA)
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015

Association between obstructive sleep apnea (OSA) and depression and the effect of continuous positive airway pressure (CPAP) treatment
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012


Prevalence and causes of residual sleepiness (RS) 12 months after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea syndome (OSAS)
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010

Study of factors affecting compliance of continuous positive airway pressure (CPAP) in obstructive sleep apnea-hypopnea syndrome (OSAHS)
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


CPAP therapy in heavy good vehicle (HGV) drivers with obstructive sleep apnoea (OSA) after 1 year: use of therapy and health status
Source: Eur Respir J 2001; 18: Suppl. 33, 418s
Year: 2001

Factors influencing the level of efficient pressure of continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea (OSAS)
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016